STAT3, a Master Regulator of Anti-Tumor Immune Response

Cancers - Switzerland
doi 10.3390/cancers11091280
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

MDPI AG

Related search

MYC: Master Regulator of Immune Privilege

Trends in Immunology
AllergyImmunology
2017English

The 6th R of Radiobiology: Reactivation of Anti-Tumor Immune Response

Cancers
Cancer ResearchOncology
2019English

Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not to Target?

Frontiers in Immunology
AllergyImmunology
2018English

HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

GRIM-19: A Master Regulator of Cytokine Induced Tumor Suppression, Metastasis and Energy Metabolism

Cytokine and Growth Factor Reviews
GeneticsMolecular BiologyBiochemistryEndocrinologyAllergyImmunologyMetabolismDiabetes
2017English

Klotho: A Master Regulator of Cardiovascular Disease?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Melittin-Lipid Nanoparticles Target to Lymph Nodes and Elicit a Systemic Anti-Tumor Immune Response

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Peripheral Neurons: Master Regulators of Skin and Mucosal Immune Response

European Journal of Immunology
AllergyImmunology
2019English

The Anti-Tumor Immune Response Induced by a Combination of MAGE-3/MAGE-n-derived Peptides

Oncology Reports
MedicineCancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy